On July 11, 2018, the House Energy & Commerce Committee’s Health Subcommittee (the Subcommittee) held a hearing titled, “Opportunities to Improve the 340B Drug Pricing Program.” In addition to hearing from two witness...more
On October 11, 2017, the House Energy & Commerce’s Oversight and Investigations Subcommittee held a hearing entitled “Examining How Covered Entities Utilize the 340B Drug Pricing Program.” This was the Subcommittee’s second...more
On July 18, 2017, the House Energy & Commerce’s Oversight and Investigations Subcommittee held a hearing on “Examining HRSA’s Oversight of the 340B Drug Pricing Program.” The hearing featured a single panel of three federal...more